Nothing Special   »   [go: up one dir, main page]

AU1787876A - N-aryl-N (1-4 piperindinyl) arylacetamides - Google Patents

N-aryl-N (1-4 piperindinyl) arylacetamides

Info

Publication number
AU1787876A
AU1787876A AU17878/76A AU1787876A AU1787876A AU 1787876 A AU1787876 A AU 1787876A AU 17878/76 A AU17878/76 A AU 17878/76A AU 1787876 A AU1787876 A AU 1787876A AU 1787876 A AU1787876 A AU 1787876A
Authority
AU
Australia
Prior art keywords
piperindinyl
arylacetamides
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU17878/76A
Other versions
AU510029B2 (en
Inventor
S. and Hermans H. K. Le Sanczuk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU1787876A publication Critical patent/AU1787876A/en
Application granted granted Critical
Publication of AU510029B2 publication Critical patent/AU510029B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU17878/76A 1975-09-23 1976-09-17 N-aryl-N (1-4 piperindinyl) arylacetamides Expired AU510029B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
USUS615131 1975-09-23
US71375676A 1976-08-12 1976-08-12
USUS713756 1976-08-12

Publications (2)

Publication Number Publication Date
AU1787876A true AU1787876A (en) 1978-03-23
AU510029B2 AU510029B2 (en) 1980-06-05

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17878/76A Expired AU510029B2 (en) 1975-09-23 1976-09-17 N-aryl-N (1-4 piperindinyl) arylacetamides

Country Status (29)

Country Link
JP (1) JPS6016417B2 (en)
AT (1) AT363935B (en)
AU (1) AU510029B2 (en)
BG (1) BG27543A3 (en)
CA (1) CA1068271A (en)
CH (1) CH628623A5 (en)
CS (1) CS222663B2 (en)
DE (1) DE2642856A1 (en)
DK (1) DK150478C (en)
ES (1) ES451768A1 (en)
FI (1) FI61482C (en)
FR (1) FR2325377A1 (en)
GB (1) GB1539473A (en)
GR (1) GR58469B (en)
HU (1) HU172964B (en)
IE (1) IE43802B1 (en)
IL (1) IL50522A (en)
IT (1) IT1073893B (en)
LU (1) LU75837A1 (en)
NL (1) NL187267C (en)
NO (1) NO147672C (en)
NZ (1) NZ181972A (en)
PH (1) PH12497A (en)
PL (2) PL192578A1 (en)
PT (1) PT65631B (en)
RO (1) RO70079A (en)
SE (1) SE427839B (en)
SU (1) SU747424A3 (en)
YU (1) YU39973B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (en) * 1986-05-08 1987-11-13 株式会社ヘキトク Line system for manufacturing smoked roof tile
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Fast Dissociting Dopamine 2 Receptor Antagonists
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Fast Dissociating Dopamine 2 Receptor Antagonists
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Fast -Dissociating Dopamine 2 Receptor Antagonists
KR20100016498A (en) * 2007-04-23 2010-02-12 얀센 파마슈티카 엔.브이. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
SI2148873T1 (en) 2007-04-23 2013-01-31 Janssen Pharmaceutica, N.V. 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
CA2682671C (en) 2007-04-23 2015-11-17 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
BRPI0915834A2 (en) 2008-07-03 2015-11-03 Janssen Pharmaceutica Nv Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists
SI2307374T1 (en) 2008-07-31 2017-05-31 Janssen Pharmaceutica Nv Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists

Also Published As

Publication number Publication date
DK427876A (en) 1977-03-24
NL7610513A (en) 1977-03-25
NO147672B (en) 1983-02-14
NZ181972A (en) 1978-07-28
SE7610501L (en) 1977-03-24
HU172964B (en) 1979-01-28
AT363935B (en) 1981-09-10
PT65631B (en) 1978-07-05
CS222663B2 (en) 1983-07-29
GR58469B (en) 1977-10-14
FR2325377A1 (en) 1977-04-22
NL187267B (en) 1991-03-01
CA1068271A (en) 1979-12-18
IL50522A (en) 1979-09-30
IL50522A0 (en) 1976-11-30
PT65631A (en) 1976-10-01
IE43802B1 (en) 1981-06-03
AU510029B2 (en) 1980-06-05
NO147672C (en) 1983-05-25
GB1539473A (en) 1979-01-31
RO70079A (en) 1982-10-26
YU233676A (en) 1983-01-21
FI61482B (en) 1982-04-30
LU75837A1 (en) 1977-05-04
SE427839B (en) 1983-05-09
DK150478C (en) 1987-10-05
IT1073893B (en) 1985-04-17
FI762698A (en) 1977-03-24
ES451768A1 (en) 1978-05-01
FI61482C (en) 1982-08-10
NL187267C (en) 1991-08-01
BG27543A3 (en) 1979-11-12
YU39973B (en) 1985-06-30
SU747424A3 (en) 1980-07-23
DE2642856A1 (en) 1977-03-24
CH628623A5 (en) 1982-03-15
IE43802L (en) 1977-03-23
DK150478B (en) 1987-03-09
ATA702976A (en) 1981-02-15
PL117323B1 (en) 1981-07-31
DE2642856C2 (en) 1990-06-21
NO763054L (en) 1977-03-24
FR2325377B1 (en) 1980-04-18
PH12497A (en) 1979-04-05
PL192578A1 (en) 1979-02-26
JPS5239683A (en) 1977-03-28
JPS6016417B2 (en) 1985-04-25

Similar Documents

Publication Publication Date Title
AU496790B2 (en) Pourer-stopper
AU1108376A (en) Polyhemoglobin
AU1006976A (en) Inhilator
AU1670276A (en) Tetrahydro-isoquinolines
AU1230276A (en) Amidinoureas
AU1230176A (en) Imidinoureas
AU2018176A (en) Pyrazinecarboxamides
AU1441776A (en) Thieno-pyridines
AU1373876A (en) Bottlecap
AU1829576A (en) Hydropyrimidines
AU1667476A (en) Chroman-4-ones
AU1128976A (en) Magneto-alternator
AU1417076A (en) Propargyl-2 phenylamino-2-impazolines
AU1710076A (en) Dihydrooxadiazinones
AU510029B2 (en) N-aryl-N (1-4 piperindinyl) arylacetamides
AU1867676A (en) N-acetylmuramyl-dorl-alanyl-dorl-isoglutamine
AU1722876A (en) Antimacassar
AU1565576A (en) L- pyroglutamyl-l-prolinamide
AU1719976A (en) Silacyclo pentenyl-bis-epsilon-caprolactam
AU1408076A (en) Lysolipin Antibioties
AU1520376A (en) Benzocycloheptathiophens
AU1191776A (en) Fluoro-prostaglandins
AU1804876A (en) 4-hydroxymethyl-2-pyrrolidinones
AU1393076A (en) Dihydromocimycin
AU1398876A (en) Aryl-di-thioureas